Towards a new standard of care for patients with myeloma?

Lancet Oncol. 2010 Jan;11(1):3-4. doi: 10.1016/S1470-2045(09)70313-4. Epub 2009 Oct 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / standards
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Dexamethasone / administration & dosage
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Humans
  • Lenalidomide
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / mortality
  • Practice Guidelines as Topic
  • Quality of Health Care
  • Risk Assessment
  • Thalidomide / administration & dosage
  • Thalidomide / analogs & derivatives
  • Time Factors
  • Treatment Outcome

Substances

  • Thalidomide
  • Dexamethasone
  • Lenalidomide